Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

Viral Vector Process Development Summit

Evvnt Promotion / evvnt
-
31.01.2023 - 02.02.2023  Omni Parker House, 60 School Street, 02108 Boston, Massachusetts, USA
Time: 9:00 am - 4:30 pm
 
Temi della conferenza
As cell and gene therapy and genomic medicine pipeline continues to mature, process development for viral vector is becoming critical for drug developers for the next phase, to deliver a quality, transformative cure to patients with affordability.
Scientific organizer
Hanson Wade
Annotazioni
URL:
Website: https://go.evvnt.com/1322215-3?pid=4832

Speakers: Rajiv Gangurde | Chief Technology Officer | SparingVision, Susan D'Costa | Executive VP and Global Head, Technology | Alcyone Therapeutics, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1322215-2?pid=4832
Ms. Stephanie Nketia
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2999.00 - USD 5396.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinÄrzte der WeltCenter of ExcellenceÖsterreichisches Rotes KreuzHelix - Forschung & Beratung WienÖsterreichische Gesellschaft für Public HealthCharité International AcademyHilfswerk Austria